Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1929258099;58100;58101 chr2:178594620;178594619;178594618chr2:179459347;179459346;179459345
N2AB1765153176;53177;53178 chr2:178594620;178594619;178594618chr2:179459347;179459346;179459345
N2A1672450395;50396;50397 chr2:178594620;178594619;178594618chr2:179459347;179459346;179459345
N2B1022730904;30905;30906 chr2:178594620;178594619;178594618chr2:179459347;179459346;179459345
Novex-11035231279;31280;31281 chr2:178594620;178594619;178594618chr2:179459347;179459346;179459345
Novex-21041931480;31481;31482 chr2:178594620;178594619;178594618chr2:179459347;179459346;179459345
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAA
  • RefSeq wild type template codon: CTT
  • Domain: Fn3-28
  • Domain position: 9
  • Structural Position: 11
  • Q(SASA): 0.4915
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/A rs1225953212 -0.555 0.625 N 0.476 0.141 0.300110245524 gnomAD-2.1.1 4.05E-06 None None None None N None 0 2.92E-05 None 0 0 None 0 None 0 0 0
E/A rs1225953212 -0.555 0.625 N 0.476 0.141 0.300110245524 gnomAD-4.0.0 1.59757E-06 None None None None N None 0 2.29632E-05 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1329 likely_benign 0.1515 benign -0.717 Destabilizing 0.625 D 0.476 neutral N 0.509360673 None None N
E/C 0.7523 likely_pathogenic 0.7869 pathogenic -0.264 Destabilizing 0.998 D 0.613 neutral None None None None N
E/D 0.208 likely_benign 0.202 benign -0.76 Destabilizing 0.801 D 0.561 neutral N 0.469229191 None None N
E/F 0.6692 likely_pathogenic 0.7021 pathogenic -0.378 Destabilizing 0.974 D 0.636 neutral None None None None N
E/G 0.2795 likely_benign 0.2914 benign -1.008 Destabilizing 0.801 D 0.602 neutral N 0.479775802 None None N
E/H 0.4081 ambiguous 0.4314 ambiguous -0.466 Destabilizing 0.974 D 0.629 neutral None None None None N
E/I 0.1975 likely_benign 0.2268 benign 0.05 Stabilizing 0.029 N 0.413 neutral None None None None N
E/K 0.177 likely_benign 0.1877 benign -0.21 Destabilizing 0.669 D 0.579 neutral N 0.445423838 None None N
E/L 0.2711 likely_benign 0.3097 benign 0.05 Stabilizing 0.525 D 0.449 neutral None None None None N
E/M 0.3189 likely_benign 0.3665 ambiguous 0.367 Stabilizing 0.974 D 0.617 neutral None None None None N
E/N 0.2771 likely_benign 0.3137 benign -0.61 Destabilizing 0.949 D 0.637 neutral None None None None N
E/P 0.9622 likely_pathogenic 0.9693 pathogenic -0.184 Destabilizing 0.974 D 0.655 neutral None None None None N
E/Q 0.1099 likely_benign 0.1271 benign -0.53 Destabilizing 0.051 N 0.286 neutral N 0.500335758 None None N
E/R 0.2903 likely_benign 0.2927 benign 0.043 Stabilizing 0.904 D 0.634 neutral None None None None N
E/S 0.2075 likely_benign 0.2356 benign -0.837 Destabilizing 0.842 D 0.588 neutral None None None None N
E/T 0.1537 likely_benign 0.179 benign -0.601 Destabilizing 0.842 D 0.59 neutral None None None None N
E/V 0.1244 likely_benign 0.1393 benign -0.184 Destabilizing 0.051 N 0.339 neutral N 0.49167899 None None N
E/W 0.8907 likely_pathogenic 0.8956 pathogenic -0.152 Destabilizing 0.998 D 0.649 neutral None None None None N
E/Y 0.605 likely_pathogenic 0.6206 pathogenic -0.13 Destabilizing 0.991 D 0.637 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.